Suspected idiopathic sclerosing orbital inflammation presenting as immunoglobulin G4-related disease: a case report by Nagai, Kazuki et al.
CASE REPORT Open Access
Suspected idiopathic sclerosing orbital
inflammation presenting as immunoglobulin
G4-related disease: a case report
Kazuki Nagai
1*, Kazuo Andoh
2, Noriko Nakamura
3 and Katsumi Sakata
4
Abstract
Introduction: Idiopathic sclerosing orbital inflammation is a rare and ill-defined heterogeneous entity, and a
distinct subset of orbital inflammation. Recently, attention has been focused on immunoglobulin G4-related disease
complicated with fibrotic changes in some other organs with high serum immunoglobulin G4 levels. This report
presents a case of suspected idiopathic sclerosing orbital inflammation complicated with high serum
immunoglobulin G4 levels.
Case presentation: An 82-year-old Japanese woman had a 30-year history of chronic thyroiditis. She experienced
right ptosis and eyelid swelling. These symptoms gradually developed over five years. The clinical and radiographic
findings suggested that our patient had idiopathic sclerosing orbital inflammation. We were unable to obtain our
patient’s consent to perform a biopsy. While the serum immunoglobulin G level was within the normal limits, the
serum immunoglobulin G4 level was significantly elevated. The serum immunoglobulin G4 levels decreased after
the administration of oral prednisolone at a daily dose of 20 mg. In addition, the swelling and ptosis of the right
upper eyelid disappeared gradually after four weeks. Our patient was then suspected to have idiopathic sclerosing
orbital inflammation complicated with immunoglobulin G4-related disease and chronic thyroiditis.
Conclusion: An orbital pseudotumor of this type is indicative of idiopathic sclerosing orbital inflammation
immunoglobulin G4-related disease. Immunoglobulin G4 may thus be considered a subclass of immunoglobulin G
when the serum immunoglobulin G level is within normal limits.
Introduction
Idiopathic sclerosing orbital inflammation (ISOI) is a
rare, distinct subset of orbital inflammation, which is
difficult to diagnose and manage. In addition, ISOI is an
ill-defined heterogeneous entity. There are many reports
on ISOI [1-4]. Early intervention with immunosuppres-
sion in the form of corticosteroids can result in the con-
trol and even regression of the disease. Various diseases
that cause fibrotic changes in different systemic organs
have been reported in cases of ISOI [5,6]. Multifocal
fibrosclerosis or systemic idiopathic fibrosis occurs when
orbital pseudotumor (OPT) is complicated by idiopathic
retroperitoneal fibrosis (IRF), sclerosing cholangitis (SC)
or Riedel’s thyroiditis [7,8]. This disease group has also
been collectively known as “fibrotic overlap syndrome”
due to its excellent response to steroids [9,10]. On the
other hand, serum immunoglobulin (Ig) G4-elevated
cases that are complicated with fibrotic changes in dif-
ferent systemic organs are known as IgG4-related auto-
immune disease [11], hyper-IgG4 disease [12,13], and
IgG4-related sclerosing disease [14-19]. Masaki et al.
proposed a new clinical entity, IgG4-positive multiorgan
lymph proliferative syndrome (MOLPS), based on the
clinical features and a good response to steroids [20].
Thus far, however, the findings have been insufficient.
In addition, no consensus has yet been reached regard-
ing the definition of IgG4-related sclerosing disease.
Recently, Umehara and Okazaki reached a consensus
regarding its name and now call it “IgG4-related dis-
ease” [20]. * Correspondence: k-nagai@biglobe.ne.jp
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indicate ISOI and may be relevant to IgG4-related dis-
ease. A subset of ISOI may include IgG4-related disease.
Case presentation
An 82-year-old Japanese woman had a 30-year history of
chronic thyroiditis. She had suffered from right ptosis
and eyelid swelling for five years. She entered another
hospital for a workup. However, she did not receive
treatment at that time and her symptoms remained
untreated. These symptoms were still persisting when
she had a check-up at our clinic.
Our patient had been administered levothyroxine
sodium hydrate for several years. She had never received
a blood transfusion, and her family history was unre-
markable. A physical examination at the time of onset
showed our patient to be well nourished; her height was
146 cm, and her weight was 52 kg. There was swelling
and ptosis of her right upper eyelid. Her thyroid gland
was not enlarged, but it was slightly hard when palpated.
Her chest and heart were normal, and no abdominal
tumor or hepatosplenomegaly were observed. There was
also no remarkable swelling in her lymph nodes or
peripheral edema in her extremities. Her neurologic
function was also normal. No bilateral hilar lymphade-
nopathy (BHL) was identified in chest X-ray findings.
Laboratory data were obtained during the check-up.
Hematologic tests were within the normal limits. Her
thyroid function tests showed free thyroxine 0.9 ng/dL
(normal range 0.8-1.7 ng/dL), free tri-iodothyronine 2.2
pg/mL (normal range 2.2-4.1 pg/mL), thyroid stimulat-
ing hormone (TSH) 1.11 μIU/mL (normal range 0.35-
3.73 μIU/mL), thyroid test × 6,400 (normal < × 100),
anti-TSH-receptor antibody 9.5% (-15~15%), anti-thyro-
globulin antibody 59.0 U/mL (normal range < 0.3 U/
mL). Autoantibody tests were negative for rheumatoid
arthritis, lupus erythematous, antinuclear antibody, anti-
DNA antibody and antimitochondrial antibody. Compu-
terized tomography (CT) of her head was subsequently
performed. A head CT of the orbit revealed an infiltra-
tion of the right intraorbital diffuse fibrotic tissues
(Figure 1a).
Our patient was followed for five years and showed
continued swelling and ptosis of her right upper eyelid.
Clinical and radiographic findings suggested her diagno-
sis to be ISOI complicated with chronic thyroiditis.
While the serum IgG level was within the normal limits
(1577; normal range 870-1700 mg/dL), the serum IgG4
level was found to be significantly elevated. The IgG
subclass was measured resulting in a IgG1 level of 643
mg/dL (normal: 320-748 mg/dL), an IgG2 level of 701
mg/dL (normal: 208-754 mg/dL), an IgG3 level of 48.9
mg/dL (normal: 6.6-88.3 mg/dL), and an IgG4 level of
185 mg/dL (normal: 4.8-105 mg/dL). Therefore, our
patient was diagnosed to have suspected ISOI compli-
cated with high serum IgG4 levels and chronic thyroidi-
tis. Oral prednisolone administration was initiated. The
serum IgG4 levels decreased dramatically. The labora-
tory data showed IgG4 94 mg/dL (Figure 2). The swel-
ling and ptosis of her right upper eyelid disappeared
gradually. In addition, magnetic resonance imaging
(MRI) revealed infiltration of the right intraorbital dif-
fuse fibrotic tissues which regressed and diminished
after four weeks (Figure 1b). After 12 months, the
laboratory data showed IgG4 64 mg/dL. Our patient is
currently healthy.
a b 
Figure 1 Patient presented with swelling and ptosis of the right upper eyelid. (a) Head CT of the orbit revealed abnormal high density
area (yellow circle); (b) MRI revealed the presence of an infiltration of the right intraorbital diffuse mass which regressed and decreased in size
one month after treatment was initiated.
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The OPT observed in this case was suspected to be
ISOI and may have been related to IgG4-related disease.
The diagnosis of IgG4-related disease is defined by both
an elevated serum IgG4 level (> 135 mg/dL) and certain
histopathological features, including lymphocyte and
IgG4 positive plasma cell infiltration (ratio of IgG4 posi-
tive plasma cells to IgG positive plasma cells > 50% on a
highly magnified slide checked at five points) [20]. In
t h ep r e s e n tc a s e ,b e c a u s eab i o p s yh a dn o tb e e np e r -
formed, the diagnostic criteria for IgG4-related disease
were not satisfied. However, despite the fact that the
serum IgG level fell within the normal range, she had
high levels of IgG4. Moreover, prednisolone was excep-
tionally effective, so an IgG4-related disease was
suspected.
Neild reported that an increased IgG concentration in
the absence of hypergammaglobulinemia is typical but,
ideally, IgG4 should also be measured [14]. While the
serum IgG level was within the normal limits in our
patient, her serum IgG4 level was significantly elevated.
It is prudent to measure blood IgG4 level in a case of
ISOI with a normal IgG level. If the value is elevated,
careful observation for the development of IRF and/or
fibrotic changes in the other organs should be con-
ducted. A strict follow-up is therefore recommended in
such cases. Normally, when IgG4-related sclerosing dis-
ease is suspected, it is necessary to conduct a histo-
pathological examination. However, in this case, we
were unable to obtain the patient’s consent to conduct a
histopathological examination.
There are a few points to consider in this case. First of
all, the question as to whether ISOI and chronic thyroi-
ditis, which appeared as complications in the present
case, were indeed related to IgG4 remains to be defini-
tively concluded. To do this a histopathological study
was required, but was not possible as we could not
obtain the permission of our patient. However, ISOI
itself is vaguely defined, and it was assumed to be an
OPT accompanying fibrosis of unknown origin. One
should take into account the possible chronic sclerosing
dacryoadenitis in the case of ISOI [21]. Regarding the
ISOI in the present case, chronic sclerosing dacryoade-
nitis, Graves’ ophthalmopathy, etc., should also be
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Figure 2 Laboratory data before and after treatment with oral prednisolone. Administration at a daily dose of 20 mg was initiated. The
serum IgG4 levels decreased dramatically. The laboratory data initially showed an IgG4 level of 94 mg/dL. After nine months this had decreased
to 64 mg/dL.
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ophthalmopathy, orbital CT and MRI findings show an
enlargement of one or more extraocular muscles. How-
ever, the imaging of ISOI normally reveals an enlarge-
ment of one or more extraocular muscles with
infiltration into the intraorbital fibrotic tissues. There
are also no gold standard diagnostic criteria for differen-
tiating ISOI from orbital lymphoid lesions or orbital cel-
lulitis. Diagnosis in such cases is therefore based on the
clinical presentation and response to treatment with
some input from CT and MRI [22]. Taking the serology
into consideration, based on the high values for IgG4,
the eye symptoms in the present case were thus believed
to indicate symptoms associated with IgG4-related
disease.
Moreover, discriminating ISOI from sarcoidosis,
Wegener’s granulomatosis, lymphoma, cancer and other
diseases is necessary. These possibilities should not be
ruled out [23]. In the present case, differential antibodies
were negative and BHL was not observed in her chest
X-rays, so the abovementioned diseases could therefore
be, to some extent, excluded. The lack of a pathological
examination meant that they could not be definitively
excluded.
The second important point to note is regards the
thyroiditis. In the present case it was considered to be
one type of chronic thyroiditis but, as with ISOI, the
high values for IgG4 are suggestive of Riedel’s thyroidi-
tis. Riedel’s thyroiditis is a chronic fibrosing disorder of
unknown etiology, often associated with “multifocal
fibrosclerosis.” Riedel’s thyroiditis is part of the IgG4-
related systemic disease spectrum. In many cases, mul-
tifocal fibrosclerosis and IgG4-related systemic disease
are probably the same entity [24]. In addition, this may
be a variation of IgG4-related disease known as IgG4-
related autoimmune disease, hyper-IgG4 disease, IgG4-
related sclerosing disease, or IgG4-positive MOLPS. In
the future, larger studies are called to elucidate the
exact mechanism and clinical characteristics of this
disorder.
Conclusion
In cases of ISOI with high IgG level or a normal IgG
level it is prudent to measure the blood IgG4 level. If
the level rises, careful observation for the develop-
ment of IRF, and/or fibrotic changes in the organs is
necessary. A strict follow-up is recommended in such
cases.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompany-
ing images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.
Abbreviations
BHL: bilateral hilar lymphadenopathy; CT: computerized tomography; Ig:
immunoglobulin; IRF: idiopathic retroperitoneal fibrosis; ISOI: idiopathic
sclerosing orbital inflammation; MOLPS: multiorgan lymph proliferative
syndrome; MRI: magnetic resonance imaging; OPT: orbital pseudotumor; SC:
sclerosing cholangitis; TSH: thyroid stimulating hormone.
Acknowledgements
English language assistance for the preparation of this manuscript was
provided by Brian Quinn, of Japan Medical Communication (Fukuoka, Japan).
Author details
1Internal Medicine, Nagai Clinic, 1-7-25, Yokodai, Isogo-ku, Yokohama City,
Kanagawa, 235-0045, Japan.
2Department of Radiology, Saiseikai Yokohama-
shi Nanbu Hospital, 3-2-10, Konandai, Konan-ku, Yokohama City, Kanagawa,
234-8503, Japan.
3Department of Pathology, Saiseikai Yokohama-shi Nanbu
Hospital, 3-2-10, Konandai, Konan-ku, Yokohama City, Kanagawa, 234-8503,
Japan.
4Department of Neurosurgery, Yokohama City University, 4-57,
Urafune-cho, Minami-ku, Yokohama City, Kanagawa, 232-0024, Japan.
Authors’ contributions
KN and KS drafted and wrote the manuscript and were involved in data
interpretation. KN was involved in the care of our patient. KA provided CT
images. NA was involved in administrative support. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 22 February 2011 Accepted: 2 September 2011
Published: 2 September 2011
References
1. Chen YM, Hu FR, Liao SL: Idiopathic sclerosing orbital inflammation–a
case series study. Ophthalmologica 2010, 224(1):55-58.
2. Sahlin S, Lignell B, Williams M, Dastmalchi M, Orrego A: Treatment of
idiopathic sclerosing inflammation of the orbit (myositis) with infliximab.
Acta Ophthalmol 2009, 87(8):906-908.
3. Brannan PA: A review of sclerosing idiopathic orbital inflammation. Curr
Opin Ophthalmol 2007, 18(5):402-404.
4. Zborowska B, Ghabrial R, Selva D, McCluskey P: Idiopathic orbital
inflammation with extraorbital extension: case series and review. Eye
(Lond) 2006, 20(1):107-113.
5. Fraile G, Rodriguez-Garcia JL, Moreno A: Primary sclerosing cholangitis
associated with systemic sclerosis. Postgrad Med J 1991, 67(784):189-192.
6. Khine AA, Prabhakaran VC, Selva D: Idiopathic sclerosing orbital
inflammation: two cases presenting with paresthesia. Ophthal Plast
Reconstr Surg 2009, 25(1):65-67.
7. Carton RW, Wong R: Multifocal fibrosclerosis manifested by vena caval
obstruction and associated with vasculitis. Ann Intern Med 1969,
70(1):81-86.
8. Laitt RD, Hubscher SG, Darby S, Elias E: Sclerosing cholangitis associated
with multifocal fibrosis: a case report. GUT 1992, 33(10):1430-1432.
9. Mitchinson MJ: The pathology of idiopathic retroperitoneal fibrosis. J Clin
Pathol 1970, 23(8):681-689.
10. Comings DE, Skubi KB, Eyes JV, Motulsky AG: Familial multifocal
fibrosclerosis. Findings suggesting that retroperitoneal fibrosis,
mediastinal fibrosis, sclerosing cholangitis, Riedel’s thyroiditis, and
pseudotumor of the orbit may be different manifestations of a single
disease. Ann Intern Med 1967, 66(5):884-892.
11. Kardar AH, Sundin T, AL-Suhaibani H, Aslam M, Peracha A, Lindstedt E:
Successful treatment of idiopathic retroperitoneal fibrosis with steroids.
Ann Saudi Med 1997, 17(4):419-422.
12. Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, Okamoto A,
Egawa N, Nakajima H: A new clinicopathological entity of IgG4-related
autoimmune disease. J Gastroenterol 2003, 38(10):982-984.
13. Sugimoto T, Morita Y, Isshiki K, Yamamoto T, Uzu T, Kashiwagi A, Horie M,
Asai T: Constrictive pericarditis as an emerging manifestation of hyper-
IgG4 disease. Int J Cardiol 2008, 130(3):e100-101.
14. Neild GH, Rodriguez-Justo M, Wall C, Connolly JO: Hyper-IgG4 disease:
report and characterisation of a new disease. BMC Med 2006, 4:23.
Nagai et al. Journal of Medical Case Reports 2011, 5:427
http://www.jmedicalcasereports.com/content/5/1/427
Page 4 of 515. Zen Y, Harada K, Sasaki M, Sato Y, Tsuneyama K, Haratake J, Kurumaya H,
Katayanagi K, Masuda S, Niwa H, Morimoto H, Miwa A, Uchiyama A,
Portmann BC, Nakanuma Y: IgG4-related sclerosing cholangitis with and
without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-
associated sclerosing cholangitis: do they belong to a spectrum of
sclerosing pancreatitis? Am J Surg Pathol 2004, 28(9):1193-1203.
16. Kamisawa T, Nakajima H, Egawa N, Funata N, Tsuruta K, Okamoto A: IgG4-
related sclerosing disease incorporating sclerosing pancreatitis,
cholangitis, sialadenitis and retroperitoneal fibrosis with
lymphadenopathy. Pancreatology 2006, 6(1-2):132-137.
17. Kamisawa T, Okamoto A: Autoimmune pancreatitis: proposal of IgG4-
related sclerosing disease. J Gastroenterol 2006, 41(7):613-625.
18. Nagai K, Hosaka H, Takahashi Y, Kubo S, Nakamura N, Andoh K: A case of
IgG4-related sclerosing disease complicated with sclerosing cholangitis,
idiopathic retroperitoneal fibrosis, and orbital pseudotumor. BMJ Case
reports 2009.
19. Zen Y, Inoue D, Kitao A, Onodera M, Abo H, Miyayama S, Gabata T,
Matsui O, Nakanuma Y: IgG4-related Lung and Pleural Disease: A
Clinicopathologic Study of 21 Cases. Am J Surg Pathol 2009,
33(12):1886-1893.
20. Masaki Y, Iwao H, Nakajima A, Miki M, Sugai S, Umehara H: IgG4-related
disease (IgG4+MOLPS) - diagnostic criteria and diagnostic problems. Curr
Immunol Rev 2011, 7:172-177.
21. Cheuk W, Yuen HK, Chan JK: Chronic sclerosing dacryoadenitis: part of
the spectrum of IgG4-related sclerosing disease? Am J Surg Pathol 2007,
31(4):643-645.
22. Kapur R, Sepahdari AR, Mafee MF, Putterman AM, Aakalu V, Wendel LJA,
Setabutr P: MR Imaging of orbital inflammatory syndrome, orbital
cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted
imaging. Am J Neuroradiol 2009, 30(1):64-70.
23. Gordon LK: A case of orbital inflammatory disease: a diagnostic and
therapeutic challenge. Eye 2006, 20:1196-1206.
24. Dahlgren M, Khosroshahi A, Nielsen GP, Dehpande V, Stone JH: Riedel’s
thyroiditis and multifocal fibrosclerosis are part of the IgG4-related
systemic disease spectrum. Arthritis Care Res 2010, 62(9):1312-1318.
doi:10.1186/1752-1947-5-427
Cite this article as: Nagai et al.: Suspected idiopathic sclerosing orbital
inflammation presenting as immunoglobulin G4-related disease: a case
report. Journal of Medical Case Reports 2011 5:427.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Nagai et al. Journal of Medical Case Reports 2011, 5:427
http://www.jmedicalcasereports.com/content/5/1/427
Page 5 of 5